EGFR-IN-92 (compound 15) is an allosteric inhibitor targeting both T790M and L858R double-mutated EGFR. It exhibits antiproliferative activity against H1975 non-small cell lung cancer (NSCLC) cells expressing these double mutations.
Formula:
C22H19N3O3
Target:
EGFR
* VAT and and shipping costs not included. Errors and price changes excepted